MBX Biosciences, Inc 10-K for FY2024
MBX Biosciences, Inc. (MBX)
10-K
2025-03-17
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
MBX Biosciences, Inc filed this 10-K on March 17, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $61.92M
- compared with a net loss of $32.56M a year earlier
- Diluted EPS
- -$5.82
- compared with -$31.96 a year earlier